{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:38:35Z","timestamp":1792809515695,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nature"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Late-stage non-small cell lung cancer (NSCLC) is rarely curable\n                    <jats:sup>1<\/jats:sup>\n                    , underscoring a need to intervene earlier in the disease process. Growing evidence suggests that antitumour T\u2009cell responses are mounted but become progressively dysregulated during early tumorigenesis\n                    <jats:sup>2,3<\/jats:sup>\n                    . Tracking and targeting preinvasive T\u2009cell regulation may inform new approaches to detect and intercept lung cancer development. Here we explore how the T\u2009cell network is remodelled during NSCLC development via multi-omic, cross-tissue immune profiling in patients with preinvasive lung lesions surveilled by autofluorescence bronchoscopy and computed tomography (CT) imaging. Effector regulatory CD4\n                    <jats:sup>+<\/jats:sup>\n                    T\u2009cells (eT\n                    <jats:sub>reg<\/jats:sub>\n                    cells) expressing basic leucine zipper ATF-like transcription factor (BATF) accumulated in high-grade premalignant airway lesions and were clonally related to circulating eT\n                    <jats:sub>reg<\/jats:sub>\n                    cells. Circulating eT\n                    <jats:sub>reg<\/jats:sub>\n                    cells were increasingly elevated during preinvasive progression, enabling lung tumorigenesis\u00a0to be tracked through analysis of peripheral blood. Emergence of this clonally coordinated eT\n                    <jats:sub>reg<\/jats:sub>\n                    cell circuit defined rapid progression in patients with early-stage NSCLC detected during\u00a0CT screening. In mice, carcinogen-driven lung tumorigenesis triggered an analogous preinvasive eT\n                    <jats:sub>reg<\/jats:sub>\n                    cell axis across the blood, airways and draining lymph nodes (dLNs). This culminated in an expansion of lung BATF\n                    <jats:sup>+<\/jats:sup>\n                    T\n                    <jats:sub>reg<\/jats:sub>\n                    cells and\u00a0T\n                    <jats:sub>reg<\/jats:sub>\n                    \u00a0cell-rich peribronchial immature tertiary lymphoid structures\u00a0(iTLSs). Immune interception via phosphoinositide 3-kinase-\u03b4 (PI3K\u03b4) inhibition abrogated formation of\u00a0T\n                    <jats:sub>reg<\/jats:sub>\n                    cell-rich\u00a0iTLSs, reduced circulating and pulmonary T\n                    <jats:sub>reg<\/jats:sub>\n                    cells, increased local conventional type\u20091 dendritic cells\u00a0(cDC1s) and reduced lung tumour incidence and size. These data reveal a conserved eT\n                    <jats:sub>reg<\/jats:sub>\n                    cell network that emerges across tissues during early pulmonary tumorigenesis and provide a theranostic framework to track and target preinvasive immune regulation for lung cancer interception.\n                  <\/jats:p>","DOI":"10.1038\/s41586-026-11066-6","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:03:34Z","timestamp":1791385414000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A preinvasive regulatory T cell axis for lung cancer interception"],"prefix":"10.1038","author":[{"given":"Samuel","family":"Gamble","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe E.","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9791-1176","authenticated-orcid":false,"given":"Claudia","family":"Peinador-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Lebrusant-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6069-5871","authenticated-orcid":false,"given":"Abigail Y. L.","family":"Shurr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8117-2207","authenticated-orcid":false,"given":"Andrei","family":"Enica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teerapon","family":"Sahwangarrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seng Kuong Anakin","family":"Ung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7071-7889","authenticated-orcid":false,"given":"Amber","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Fessas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuen Ryan","family":"Khaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Kalinke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Ahlmann-Eltze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1883-2142","authenticated-orcid":false,"given":"Ahmed S. N.","family":"Alhendi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Otter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuchuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krupa","family":"Thakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betty","family":"Gration","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0816-4045","authenticated-orcid":false,"given":"Izzy","family":"Newsham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0736-3149","authenticated-orcid":false,"given":"Imran","family":"Uddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0395-3304","authenticated-orcid":false,"given":"Ellen Nuttall","family":"Musson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyren A.","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5645-9492","authenticated-orcid":false,"given":"Moritz J.","family":"Przybilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Pennycuick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Hagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Percival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Prendecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Tisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Constantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal F.","family":"Durrenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Pre-Cancer Atlas Team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate H. C.","family":"Gowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yien Ning Sophia","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Linch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3725-0914","authenticated-orcid":false,"given":"Kevin","family":"Litchfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5841-778X","authenticated-orcid":false,"given":"Elspeth M.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9219-3350","authenticated-orcid":false,"given":"Se-Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9763-1700","authenticated-orcid":false,"given":"Sergio A.","family":"Quezada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3921-0510","authenticated-orcid":false,"given":"Peter J.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6699-2132","authenticated-orcid":false,"given":"Jennifer E.","family":"Beane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Mazzilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6296-1312","authenticated-orcid":false,"given":"David A.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0090-861X","authenticated-orcid":false,"given":"Vitor H.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5163-6066","authenticated-orcid":false,"given":"Sandra","family":"G\u00f3mez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7074-3673","authenticated-orcid":false,"given":"Bart","family":"Vanhaesebroeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6634-5939","authenticated-orcid":false,"given":"Sam M.","family":"Janes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5381-978X","authenticated-orcid":false,"given":"James L.","family":"Reading","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"key":"11066_CR1","unstructured":"World Health Organization. Lung cancer. WHO https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/lung-cancer (2026)."},{"key":"11066_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.immuni.2016.07.011","volume":"45","author":"A Schietinger","year":"2016","unstructured":"Schietinger, A. et al. Tumor-specific T cell dysfunction is a dynamic antigen-driven differentiation program initiated early during tumorigenesis. Immunity 45, 389\u2013401 (2016).","journal-title":"Immunity"},{"key":"11066_CR3","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1158\/2159-8290.CD-19-1366","volume":"10","author":"A Pennycuick","year":"2020","unstructured":"Pennycuick, A. et al. Immune surveillance in clinical regression of preinvasive squamous cell lung cancer. Cancer Discov. 10, 1489\u20131499 (2020).","journal-title":"Cancer Discov."},{"key":"11066_CR4","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abk0957","volume":"7","author":"K Itahashi","year":"2022","unstructured":"Itahashi, K. et al. BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors. Sci. Immunol. 7, eabk0957 (2022).","journal-title":"Sci. Immunol."},{"key":"11066_CR5","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1172\/JCI130426","volume":"130","author":"G Alvisi","year":"2020","unstructured":"Alvisi, G. et al. IRF4 instructs effector Treg differentiation and immune suppression in human cancer. J. Clin. Invest. 130, 3137\u20133150 (2020).","journal-title":"J. Clin. Invest."},{"key":"11066_CR6","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adg1487","volume":"8","author":"AG Dykema","year":"2023","unstructured":"Dykema, A. G. et al. Lung tumor-infiltrating Treg have divergent transcriptional profiles and function linked to checkpoint blockade response. Sci. Immunol. 8, eadg1487 (2023).","journal-title":"Sci. Immunol."},{"key":"11066_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aao4310","volume":"4","author":"M Ahmadzadeh","year":"2019","unstructured":"Ahmadzadeh, M. et al. Tumor-infiltrating human CD4+ regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity. Sci. Immunol. 4, eaao4310 (2019).","journal-title":"Sci. Immunol."},{"key":"11066_CR8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.immuni.2015.08.006","volume":"43","author":"NS Joshi","year":"2015","unstructured":"Joshi, N. S. et al. Regulatory T cells in tumor-associated tertiary lymphoid structures suppress anti-tumor T cell responses. Immunity 43, 579\u2013590 (2015).","journal-title":"Immunity"},{"key":"11066_CR9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.immuni.2023.01.010","volume":"56","author":"M Zagorulya","year":"2023","unstructured":"Zagorulya, M. et al. Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer. Immunity 56, 386\u2013405 (2023).","journal-title":"Immunity"},{"key":"11066_CR10","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/s41586-021-03651-8","volume":"595","author":"M Casanova-Acebes","year":"2021","unstructured":"Casanova-Acebes, M. et al. Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells. Nature 595, 578\u2013584 (2021).","journal-title":"Nature"},{"key":"11066_CR11","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/j.immuni.2021.08.026","volume":"54","author":"JM Schenkel","year":"2021","unstructured":"Schenkel, J. M. et al. Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1+CD8+ T cells in the tumor draining lymph nodes. Immunity 54, 2338\u20132353.e6 (2021).","journal-title":"Immunity"},{"key":"11066_CR12","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abg7836","volume":"6","author":"KA Connolly","year":"2021","unstructured":"Connolly, K. A. et al. A reservoir of stem-like CD8+ T cells in the tumor-draining lymph node preserves the ongoing antitumor immune response. Sci. Immunol. 6, eabg7836 (2021).","journal-title":"Sci. Immunol."},{"key":"11066_CR13","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41586-019-1330-0","volume":"571","author":"C Mascaux","year":"2019","unstructured":"Mascaux, C. et al. Immune evasion before tumour invasion in early lung squamous carcinogenesis. Nature 571, 570\u2013575 (2019).","journal-title":"Nature"},{"key":"11066_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41568-025-00791-1","volume":"25","author":"SA Mazzilli","year":"2025","unstructured":"Mazzilli, S. A. et al. Translating premalignant biology to accelerate non-small-cell lung cancer interception. Nat. Rev. Cancer 25, 379\u2013392 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"11066_CR15","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ctrv.2017.05.009","volume":"58","author":"RM Thakrar","year":"2017","unstructured":"Thakrar, R. M., Pennycuick, A., Borg, E. & Janes, S. M. Preinvasive disease of the airway. Cancer Treat. Rev. 58, 77\u201390 (2017).","journal-title":"Cancer Treat. Rev."},{"key":"11066_CR16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41591-018-0323-0","volume":"25","author":"VH Teixeira","year":"2019","unstructured":"Teixeira, V. H. et al. Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions. Nat. Med. 25, 517\u2013525 (2019).","journal-title":"Nat. Med."},{"key":"11066_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/thx.2005.052191","volume":"62","author":"P Jeremy George","year":"2007","unstructured":"Jeremy George, P. et al. Surveillance for the detection of early lung cancer in patients with bronchial dysplasia. Thorax 62, 43\u201350 (2007).","journal-title":"Thorax"},{"key":"11066_CR18","unstructured":"Thakrar, R. & George, J. Longitudinal study of patients with pre-invasive lesions of the bronchus. University College London Hospitals https:\/\/findastudy.uclh.nhs.uk\/trial\/6895d22abdb63737847155f5\/view (2022)."},{"key":"11066_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).","journal-title":"Science"},{"key":"11066_CR20","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.ccell.2022.10.008","volume":"40","author":"S Salcher","year":"2022","unstructured":"Salcher, S. et al. High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in non-small cell lung cancer. Cancer Cell 40, 1503\u20131520 (2022).","journal-title":"Cancer Cell"},{"key":"11066_CR21","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1038\/s12276-022-00896-9","volume":"54","author":"J Zhu","year":"2022","unstructured":"Zhu, J. et al. Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics. Exp. Mol. Med. 54, 2060\u20132076 (2022).","journal-title":"Exp. Mol. Med."},{"key":"11066_CR22","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1158\/1940-6207.CAPR-16-0024","volume":"9","author":"JD Campbell","year":"2016","unstructured":"Campbell, J. D. et al. The case for a pre-cancer genome atlas (PCGA). Cancer Prev. Res. 9, 119\u2013124 (2016).","journal-title":"Cancer Prev. Res."},{"key":"11066_CR23","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.1158\/0008-5472.CAN-23-0128","volume":"83","author":"J Yanagawa","year":"2023","unstructured":"Yanagawa, J. et al. Single-cell characterization of pulmonary nodules implicates suppression of immunosurveillance across early stages of lung adenocarcinoma. Cancer Res. 83, 3305\u20133319 (2023).","journal-title":"Cancer Res."},{"key":"11066_CR24","doi-asserted-by":"publisher","first-page":"5701","DOI":"10.1093\/bioinformatics\/btaa1009","volume":"36","author":"C Ahlmann-Eltze","year":"2020","unstructured":"Ahlmann-Eltze, C. & Huber, W. glmGamPoi: fitting Gamma-Poisson generalized linear models on single cell count data. Bioinformatics 36, 5701\u20135702 (2020).","journal-title":"Bioinformatics"},{"key":"11066_CR25","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41591-018-0045-3","volume":"24","author":"X Guo","year":"2018","unstructured":"Guo, X. et al. Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing. Nat. Med. 24, 978\u2013985 (2018).","journal-title":"Nat. Med."},{"key":"11066_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adf6717","volume":"8","author":"F Shan","year":"2023","unstructured":"Shan, F. et al. Integrated BATF transcriptional network regulates suppressive intratumoral regulatory T cells. Sci. Immunol. 8, eadf6717 (2023).","journal-title":"Sci. Immunol."},{"key":"11066_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48310-4","volume":"15","author":"J Kang","year":"2024","unstructured":"Kang, J. et al. Systematic dissection of tumor\u2013normal single-cell ecosystems across a thousand tumors of 30 cancer types. Nat. Commun. 15, 4067 (2024).","journal-title":"Nat. Commun."},{"key":"11066_CR28","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.annonc.2020.04.004","volume":"31","author":"JH Shim","year":"2020","unstructured":"Shim, J. H. et al. HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients. Ann. Oncol. 31, 902\u2013911 (2020).","journal-title":"Ann. Oncol."},{"key":"11066_CR29","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","volume":"19","author":"M Andreatta","year":"2021","unstructured":"Andreatta, M. & Carmona, S. J. UCell: robust and scalable single-cell gene signature scoring. Comput. Struct. Biotechnol. J. 19, 3796\u20133798 (2021).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"11066_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"11066_CR31","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s43018-020-0066-y","volume":"1","author":"E Ghorani","year":"2020","unstructured":"Ghorani, E. et al. The T cell differentiation landscape is shaped by tumour mutations in lung cancer. Nat. Cancer 1, 546\u2013561 (2020).","journal-title":"Nat. Cancer"},{"key":"11066_CR32","unstructured":"University College, London. Analysis of Screen-Detected Lung Cancers' Genomic Traits (ASCENT) https:\/\/clinicaltrials.gov\/study\/NCT04204499 (ClinicalTrials.gov, 2025)."},{"key":"11066_CR33","unstructured":"Janes, S. Biomarkers in lung health checks (ALPINE). Health Research Authority https:\/\/go.nature.com\/47nwso4 (2023)."},{"key":"11066_CR34","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(25)00082-8","volume":"26","author":"A Bhamani","year":"2025","unstructured":"Bhamani, A. et al. Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort study. Lancet Oncol. 26, 609\u2013619 (2025).","journal-title":"Lancet Oncol."},{"key":"11066_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/science.ads9145","volume":"388","author":"S G\u00f3mez-L\u00f3pez","year":"2025","unstructured":"G\u00f3mez-L\u00f3pez, S. et al. Aberrant basal cell clonal dynamics shape early lung carcinogenesis. Science 388, eads9145 (2025).","journal-title":"Science"},{"key":"11066_CR36","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ccell.2020.09.001","volume":"38","author":"F Dammeijer","year":"2020","unstructured":"Dammeijer, F. et al. The PD-1\/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes. Cancer Cell 38, 685\u2013700 (2020).","journal-title":"Cancer Cell"},{"key":"11066_CR37","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.ccell.2024.06.014","volume":"42","author":"S You","year":"2024","unstructured":"You, S. et al. Lymphatic-localized Treg\u2013mregDC crosstalk limits antigen trafficking and restrains anti-tumor immunity. Cancer Cell 42, 1415\u20131433 (2024).","journal-title":"Cancer Cell"},{"key":"11066_CR38","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1084\/jem.20090847","volume":"206","author":"LM Francisco","year":"2009","unstructured":"Francisco, L. M. et al. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206, 3015\u20133029 (2009).","journal-title":"J. Exp. Med."},{"key":"11066_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04524-x","volume":"9","author":"R Alonso","year":"2018","unstructured":"Alonso, R. et al. Induction of anergic or regulatory tumor-specific CD4+ T cells in the tumor-draining lymph node. Nat. Commun. 9, 2113 (2018).","journal-title":"Nat. Commun."},{"key":"11066_CR40","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nature13444","volume":"510","author":"K Ali","year":"2014","unstructured":"Ali, K. et al. Inactivation of PI(3)K p110\u03b4 breaks regulatory T-cell-mediated immune tolerance to cancer. Nature 510, 407\u2013411 (2014).","journal-title":"Nature"},{"key":"11066_CR41","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa1315226","volume":"370","author":"RR Furman","year":"2014","unstructured":"Furman, R. R. et al. Idelalisib and rituximab in relapsed chronic lymphocytic leukemia. N. Engl. J. Med. 370, 997\u20131007 (2014).","journal-title":"N. Engl. J. Med."},{"key":"11066_CR42","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41586-022-04685-2","volume":"605","author":"S Eschweiler","year":"2022","unstructured":"Eschweiler, S. et al. Intermittent PI3K\u03b4 inhibition sustains anti-tumour immunity and curbs irAEs. Nature 605, 741\u2013746 (2022).","journal-title":"Nature"},{"key":"11066_CR43","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.4049\/jimmunol.1701703","volume":"202","author":"S Chellappa","year":"2019","unstructured":"Chellappa, S. et al. The PI3K p110\u03b4 isoform inhibitor idelalisib preferentially inhibits human regulatory T cell function. J. Immunol. 202, 1397\u20131405 (2019).","journal-title":"J. Immunol."},{"key":"11066_CR44","doi-asserted-by":"publisher","first-page":"e000693","DOI":"10.1136\/jitc-2020-000693","volume":"8","author":"SN Lauder","year":"2020","unstructured":"Lauder, S. N. et al. Enhanced antitumor immunity through sequential targeting of PI3K\u03b4 and LAG3. J. Immunother. Cancer 8, e000693 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"11066_CR45","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1158\/1535-7163.MCT-13-0865","volume":"13","author":"C Fritsch","year":"2014","unstructured":"Fritsch, C. et al. Characterization of the novel and specific PI3K\u03b1 inhibitor NVP-BYL719 and development of the patient stratification strategy for clinical trials. Mol. Cancer Ther. 13, 1117\u20131129 (2014).","journal-title":"Mol. Cancer Ther."},{"key":"11066_CR46","doi-asserted-by":"publisher","first-page":"5673","DOI":"10.4049\/jimmunol.0900432","volume":"183","author":"CA Durand","year":"2009","unstructured":"Durand, C. A. et al. Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses. J. Immunol. 183, 5673\u20135684 (2009).","journal-title":"J. Immunol."},{"key":"11066_CR47","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1038\/s42003-022-04356-y","volume":"5","author":"P Devi-Marulkar","year":"2022","unstructured":"Devi-Marulkar, P. et al. Regulatory T cells infiltrate the tumor-induced tertiary lymphoid structures and are associated with poor clinical outcome in NSCLC. Commun. Biol. 5, 1416 (2022).","journal-title":"Commun. Biol."},{"key":"11066_CR48","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s43018-020-00133-0","volume":"1","author":"I Solomon","year":"2020","unstructured":"Solomon, I. et al. CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity. Nat. Cancer 1, 1153\u20131166 (2020).","journal-title":"Nat. Cancer"},{"key":"11066_CR49","doi-asserted-by":"publisher","first-page":"eabg3551","DOI":"10.1126\/sciimmunol.abg3551","volume":"6","author":"H du Bois","year":"2021","unstructured":"du Bois, H., Heim, T. A. & Lund, A. W. Tumor-draining lymph nodes: at the crossroads of metastasis and immunity. Sci. Immunol. 6, eabg3551 (2021).","journal-title":"Sci. Immunol."},{"key":"11066_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abd5778","volume":"6","author":"P Gueguen","year":"2021","unstructured":"Gueguen, P. et al. Contribution of resident and circulating precursors to tumor-infiltrating CD8+ T cell populations in lung cancer. Sci. Immunol. 6, eabd5778 https:\/\/doi.org\/10.1126\/sciimmunol.abd5778 (2021).","journal-title":"Sci. Immunol."},{"key":"11066_CR51","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41586-024-08076-7","volume":"636","author":"MA Cardenas","year":"2024","unstructured":"Cardenas, M. A. et al. Differentiation fate of a stem-like CD4 T cell controls immunity to cancer. Nature 636, 224\u2013232 (2024).","journal-title":"Nature"},{"key":"11066_CR52","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adl6464","volume":"10","author":"M Cole","year":"2024","unstructured":"Cole, M. et al. Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor\u2013induced immune responses. Sci. Adv. 10, eadl6464 https:\/\/doi.org\/10.1126\/sciadv.adl6464 (2024).","journal-title":"Sci. Adv."},{"key":"11066_CR53","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1038\/s41416-022-01917-0","volume":"127","author":"SN Lauder","year":"2022","unstructured":"Lauder, S. N. et al. Treg-driven tumour control by PI3K\u03b4 inhibition limits myeloid-derived suppressor cell expansion. Br. J. Cancer 127, 1595\u20131602 (2022).","journal-title":"Br. J. Cancer"},{"key":"11066_CR54","doi-asserted-by":"publisher","unstructured":"Maio, M. et al. Tolerability and clinical benefit assessment of continuous roginolisib administration in patients with cancer including metastatic uveal melanoma. Preprint at Research Square https:\/\/doi.org\/10.21203\/rs.3.rs-8048398\/v1 (2025).","DOI":"10.21203\/rs.3.rs-8048398\/v1"},{"key":"11066_CR55","doi-asserted-by":"publisher","first-page":"115331","DOI":"10.1016\/j.ejmech.2023.115331","volume":"254","author":"R Mazzucato","year":"2023","unstructured":"Mazzucato, R. et al. Application of an \u201cinhalation by design\u201d approach to the identification and in-vitro evaluation of novel purine based PI3K\u03b4 inhibitors. Eur. J. Med. Chem. 254, 115331 (2023).","journal-title":"Eur. J. Med. Chem."},{"key":"11066_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.xjon.2023.07.004","volume":"16","author":"AR Brownlee","year":"2023","unstructured":"Brownlee, A. R. et al. Robotic navigational bronchoscopy in a thoracic surgery practice: leveraging technology in the management of pulmonary nodules. JTCVS Open 16, 1\u20136 (2023).","journal-title":"JTCVS Open"},{"key":"11066_CR57","unstructured":"Janes, S. Pathogenesis of lung disease II. Health Research Authority https:\/\/go.nature.com\/4dVZC19 (2018)."},{"key":"11066_CR58","doi-asserted-by":"publisher","first-page":"2000816","DOI":"10.1183\/13993003.00816-2020","volume":"59","author":"L Succony","year":"2022","unstructured":"Succony, L. et al. Lrig1 expression identifies airway basal cells with high proliferative capacity and restricts lung squamous cell carcinoma growth. Eur. Respir. J. 59, 2000816 (2022).","journal-title":"Eur. Respir. J."},{"key":"11066_CR59","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.26575","volume":"6","author":"MZ Nikoli\u0107","year":"2017","unstructured":"Nikoli\u0107, M. Z. et al. Human embryonic lung epithelial tips are multipotent progenitors that can be expanded in vitro as long-term self-renewing organoids. eLife 6, e26575 (2017).","journal-title":"eLife"},{"key":"11066_CR60","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587 (2021).","journal-title":"Cell"},{"key":"11066_CR61","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.cell.2020.04.017","volume":"181","author":"H Li","year":"2020","unstructured":"Li, H. et al. Dysfunctional CD8 T cells form a proliferative, dynamically regulated compartment within human melanoma. Cell 181, 747 (2020).","journal-title":"Cell"},{"key":"11066_CR62","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1038\/s41591-023-02327-2","volume":"29","author":"L Sikkema","year":"2023","unstructured":"Sikkema, L. et al. An integrated cell atlas of the lung in health and disease. Nat. Med. 29, 1563\u20131577 (2023).","journal-title":"Nat. Med."},{"key":"11066_CR63","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41392-022-01150-4","volume":"7","author":"Y Tian","year":"2022","unstructured":"Tian, Y. et al. Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer. Signal. Transduct. Target. Ther. 7, 346 (2022).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"11066_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22801-0","volume":"12","author":"F Wu","year":"2021","unstructured":"Wu, F. et al. Single-cell profiling of tumor heterogeneity and the microenvironment in advanced non-small cell lung cancer. Nat. Commun. 12, 2540 (2021).","journal-title":"Nat. Commun."},{"key":"11066_CR65","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.ccell.2024.09.011","volume":"42","author":"E Fitzsimons","year":"2024","unstructured":"Fitzsimons, E. et al. A pan-cancer single-cell RNA-seq atlas of intratumoral B cells. Cancer Cell 42, 1784\u20131797 (2024).","journal-title":"Cancer Cell"},{"key":"11066_CR66","doi-asserted-by":"publisher","first-page":"112839","DOI":"10.1016\/j.celrep.2023.112839","volume":"42","author":"DS Shin","year":"2023","unstructured":"Shin, D. S. et al. Lung injury induces a polarized immune response by self-antigen-specific CD4+ Foxp3+ regulatory T cells. Cell Rep. 42, 112839 (2023).","journal-title":"Cell Rep."},{"key":"11066_CR67","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41586-021-03752-4","volume":"596","author":"JX Caushi","year":"2021","unstructured":"Caushi, J. X. et al. Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers. Nature 596, 126\u2013132 (2021).","journal-title":"Nature"},{"key":"11066_CR68","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41587-021-01033-z","volume":"40","author":"E Dann","year":"2022","unstructured":"Dann, E., Henderson, N. C., Teichmann, S. A., Morgan, M. D. & Marioni, J. C. Differential abundance testing on single-cell data using k-nearest neighbor graphs. Nat. Biotechnol. 40, 245\u2013253 (2022).","journal-title":"Nat. Biotechnol."},{"key":"11066_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin, S. et al. Inference and analysis of cell-cell communication using CellChat. Nat. Commun. 12, 1088 (2021).","journal-title":"Nat. Commun."},{"key":"11066_CR70","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.11622.4","volume":"6","author":"M Nowicka","year":"2019","unstructured":"Nowicka, M. et al. CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets. F1000Research 6, 748 https:\/\/doi.org\/10.12688\/f1000research.11622.4 (2019).","journal-title":"F1000Research"},{"key":"11066_CR71","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1093\/bioinformatics\/btw191","volume":"32","author":"G Monaco","year":"2016","unstructured":"Monaco, G. et al. flowAI: automatic and interactive anomaly discerning tools for flow cytometry data. Bioinformatics 32, 2473\u20132480 https:\/\/doi.org\/10.1093\/bioinformatics\/btw191 (2016).","journal-title":"Bioinformatics"},{"key":"11066_CR72","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.cels.2018.02.010","volume":"6","author":"S Chevrier","year":"2018","unstructured":"Chevrier, S. et al. Compensation of signal spillover in suspension and imaging mass cytometry. Cell Syst. 6, 612\u2013620.e5 (2018).","journal-title":"Cell Syst"},{"key":"11066_CR73","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1002\/cyto.a.22625","volume":"87","author":"S Van Gassen","year":"2015","unstructured":"Van Gassen, S. et al. FlowSOM: using self-organizing maps for visualization and interpretation of cytometry data. Cytometry A 87, 636\u2013645 (2015).","journal-title":"Cytometry A"},{"key":"11066_CR74","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572\u20131573 (2010).","journal-title":"Bioinformatics"},{"key":"11066_CR75","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","volume":"38","author":"PA Ewels","year":"2020","unstructured":"Ewels, P. A. et al. The nf-core framework for community-curated bioinformatics pipelines. Nat. Biotechnol. 38, 276\u2013278 (2020).","journal-title":"Nat. Biotechnol."},{"key":"11066_CR76","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"11066_CR77","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"11066_CR78","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","volume":"4","author":"C Soneson","year":"2015","unstructured":"Soneson, C., Love, M. I. & Robinson, M. D. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Research 4, 1521 (2015).","journal-title":"F1000Research"},{"key":"11066_CR79","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels, P., Magnusson, M., Lundin, S. & K\u00e4ller, M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics 32, 3047\u20133048 (2016).","journal-title":"Bioinformatics"},{"key":"11066_CR80","doi-asserted-by":"publisher","unstructured":"Enica, A., Fessas, P., Gamble., S. Supplementary Data for: \u201cA preinvasive regulatory T cell axis for lung cancer interception\u201d. Zenodo https:\/\/doi.org\/10.5281\/zenodo.19599892 (2026).","DOI":"10.5281\/zenodo.19599892"}],"container-title":["Nature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11066-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11066-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11066-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:02:13Z","timestamp":1792807333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41586-026-11066-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":80,"alternative-id":["11066"],"URL":"https:\/\/doi.org\/10.1038\/s41586-026-11066-6","relation":{},"ISSN":["0028-0836","1476-4687"],"issn-type":[{"value":"0028-0836","type":"print"},{"value":"1476-4687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"19 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.L.R. reports speaker fees from Boehringer Ingelheim and GlaxoSmithKline. J.L.R. and S.M.J. have filed patents for cancer early detection (PCT\/EP2023\/076521 and PCT\/EP2023\/076511), on which S.G., C.P.-M., and V.H.T. are co-inventors. B.V. is a consultant for iOnctura (Geneva, Switzerland), a shareholder of Open Orphan and Poolbeg and a director of S&B Scientific. S.M.J. has received fees for advisory board membership in the past 3\u2009years from Bard1 Lifescience. He has received grant income from GRAIL. He is an unpaid member of a GRAIL advisory board. He has received lecture fees for academic meetings from Chiesi and AstraZeneca. His wife worked for Astra Zeneca. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}